BindingDB logo
myBDB logout

Patent code US11008301

Compile Data Set for Download or QSAR
Found 42 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497395
PNG
(US11008301, Example 12)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CC3(COC3)C2)nc1
Show InChI InChI=1S/C23H24F3N5O3/c24-23(25,26)15-3-8-19(27-10-15)29-21(33)28-18-2-1-9-31(20(18)32)17-6-4-16(5-7-17)30-11-22(12-30)13-34-14-22/h3-8,10,18H,1-2,9,11-14H2,(H2,27,28,29,33)/t18-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 5.00E+3n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497412
PNG
(US11008301, Example 104)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(nc2)N2C[C@@H]3CC[C@H](C2)O3)cc1
Show InChI InChI=1S/C24H26F3N5O3/c25-24(26,27)15-3-5-16(6-4-15)29-23(34)30-20-2-1-11-32(22(20)33)17-7-10-21(28-12-17)31-13-18-8-9-19(14-31)35-18/h3-7,10,12,18-20H,1-2,8-9,11,13-14H2,(H2,29,30,34)/t18-,19+,20-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 18n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497402
PNG
(US11008301, Example 50)
Show SMILES Fc1cc(ccc1N1CCC[C@@H](NC(=O)Nc2ccc(nc2)C(F)(F)F)C1=O)N1CCCCC1=O
Show InChI InChI=1S/C23H23F4N5O3/c24-16-12-15(31-10-2-1-5-20(31)33)7-8-18(16)32-11-3-4-17(21(32)34)30-22(35)29-14-6-9-19(28-13-14)23(25,26)27/h6-9,12-13,17H,1-5,10-11H2,(H2,29,30,35)/t17-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497405
PNG
(US11008301, Example 69)
Show SMILES CC(=O)N[C@@H]1CCN(C1)c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C25H28F3N5O3/c1-16(34)29-19-12-14-32(15-19)20-8-10-21(11-9-20)33-13-2-3-22(23(33)35)31-24(36)30-18-6-4-17(5-7-18)25(26,27)28/h4-11,19,22H,2-3,12-15H2,1H3,(H,29,34)(H2,30,31,36)/t19-,22-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 190n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497408
PNG
(US11008301, Example 81)
Show SMILES CN(C)C1CCN(C1)c1ccc(N2CCC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1
Show InChI InChI=1S/C24H28ClF2N5O2/c1-30(2)17-9-11-31(14-17)16-6-8-22(19(27)13-16)32-10-3-4-21(23(32)33)29-24(34)28-20-7-5-15(25)12-18(20)26/h5-8,12-13,17,21H,3-4,9-11,14H2,1-2H3,(H2,28,29,34)/t17?,21-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 1.70E+3n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497413
PNG
(US11008301, Example 107)
Show SMILES Fc1cc(ccc1N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O)N1C[C@@H]2CC[C@H](C1)O2
Show InChI InChI=1S/C24H26ClFN4O3/c25-15-3-5-16(6-4-15)27-24(32)28-21-2-1-11-30(23(21)31)22-10-7-17(12-20(22)26)29-13-18-8-9-19(14-29)33-18/h3-7,10,12,18-19,21H,1-2,8-9,11,13-14H2,(H2,27,28,32)/t18-,19+,21-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 330n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497395
PNG
(US11008301, Example 12)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CC3(COC3)C2)nc1
Show InChI InChI=1S/C23H24F3N5O3/c24-23(25,26)15-3-8-19(27-10-15)29-21(33)28-18-2-1-9-31(20(18)32)17-6-4-16(5-7-17)30-11-22(12-30)13-34-14-22/h3-8,10,18H,1-2,9,11-14H2,(H2,27,28,29,33)/t18-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 380n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497400
PNG
(US11008301, Example 34)
Show SMILES CS(=O)(=O)N1CCN(CC1)c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C24H28F3N5O4S/c1-37(35,36)31-15-13-30(14-16-31)19-8-10-20(11-9-19)32-12-2-3-21(22(32)33)29-23(34)28-18-6-4-17(5-7-18)24(25,26)27/h4-11,21H,2-3,12-16H2,1H3,(H2,28,29,34)/t21-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 400n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497403
PNG
(US11008301, Example 54)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(nc2)N2CCOCC2)cc1
Show InChI InChI=1S/C22H24F3N5O3/c23-22(24,25)15-3-5-16(6-4-15)27-21(32)28-18-2-1-9-30(20(18)31)17-7-8-19(26-14-17)29-10-12-33-13-11-29/h3-8,14,18H,1-2,9-13H2,(H2,27,28,32)/t18-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 920n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497404
PNG
(US11008301, Example 56)
Show SMILES OCC1CCCN(C1)c1ccc(cn1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C24H28F3N5O3/c25-24(26,27)17-5-7-18(8-6-17)29-23(35)30-20-4-2-12-32(22(20)34)19-9-10-21(28-13-19)31-11-1-3-16(14-31)15-33/h5-10,13,16,20,33H,1-4,11-12,14-15H2,(H2,29,30,35)/t16?,20-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 45n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497405
PNG
(US11008301, Example 69)
Show SMILES CC(=O)N[C@@H]1CCN(C1)c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C25H28F3N5O3/c1-16(34)29-19-12-14-32(15-19)20-8-10-21(11-9-20)33-13-2-3-22(23(33)35)31-24(36)30-18-6-4-17(5-7-18)25(26,27)28/h4-11,19,22H,2-3,12-15H2,1H3,(H,29,34)(H2,30,31,36)/t19-,22-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 14n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497406
PNG
(US11008301, Example 70)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCCC(F)(F)C2)cc1
Show InChI InChI=1S/C24H25F5N4O2/c25-23(26)12-2-13-32(15-23)18-8-10-19(11-9-18)33-14-1-3-20(21(33)34)31-22(35)30-17-6-4-16(5-7-17)24(27,28)29/h4-11,20H,1-3,12-15H2,(H2,30,31,35)/t20-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 2.40n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497409
PNG
(US11008301, Example 83)
Show SMILES CN(C)C1CCN(C1)c1ccc(cc1F)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O
Show InChI InChI=1S/C24H29ClFN5O2/c1-29(2)19-11-13-30(15-19)22-10-9-18(14-20(22)26)31-12-3-4-21(23(31)32)28-24(33)27-17-7-5-16(25)6-8-17/h5-10,14,19,21H,3-4,11-13,15H2,1-2H3,(H2,27,28,33)/t19?,21-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 0.390n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497411
PNG
(US11008301, Example 102)
Show SMILES Clc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCC3(CCCO3)CC2)cc1
Show InChI InChI=1S/C26H31ClN4O3/c27-19-4-6-20(7-5-19)28-25(33)29-23-3-1-15-31(24(23)32)22-10-8-21(9-11-22)30-16-13-26(14-17-30)12-2-18-34-26/h4-11,23H,1-3,12-18H2,(H2,28,29,33)/t23-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 15n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497413
PNG
(US11008301, Example 107)
Show SMILES Fc1cc(ccc1N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O)N1C[C@@H]2CC[C@H](C1)O2
Show InChI InChI=1S/C24H26ClFN4O3/c25-15-3-5-16(6-4-15)27-24(32)28-21-2-1-11-30(23(21)31)22-10-7-17(12-20(22)26)29-13-18-8-9-19(14-29)33-18/h3-7,10,12,18-19,21H,1-2,8-9,11,13-14H2,(H2,27,28,32)/t18-,19+,21-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 2.60n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497397
PNG
(US11008301, Example 15)
Show SMILES COCC1CCCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(nc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C25H30F3N5O3/c1-36-16-20-5-2-3-13-32(20)18-8-10-19(11-9-18)33-14-4-6-21(23(33)34)31-24(35)30-17-7-12-22(29-15-17)25(26,27)28/h7-12,15,20-21H,2-6,13-14,16H2,1H3,(H2,30,31,35)/t20?,21-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 32n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497399
PNG
(US11008301, Example 26)
Show SMILES COC[C@@H]1CCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O
Show InChI InChI=1S/C24H29ClN4O3/c1-32-16-21-4-2-14-28(21)19-10-12-20(13-11-19)29-15-3-5-22(23(29)30)27-24(31)26-18-8-6-17(25)7-9-18/h6-13,21-22H,2-5,14-16H2,1H3,(H2,26,27,31)/t21-,22+/m0/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 3.70n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497399
PNG
(US11008301, Example 26)
Show SMILES COC[C@@H]1CCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O
Show InChI InChI=1S/C24H29ClN4O3/c1-32-16-21-4-2-14-28(21)19-10-12-20(13-11-19)29-15-3-5-22(23(29)30)27-24(31)26-18-8-6-17(25)7-9-18/h6-13,21-22H,2-5,14-16H2,1H3,(H2,26,27,31)/t21-,22+/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 12n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497400
PNG
(US11008301, Example 34)
Show SMILES CS(=O)(=O)N1CCN(CC1)c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C24H28F3N5O4S/c1-37(35,36)31-15-13-30(14-16-31)19-8-10-20(11-9-19)32-12-2-3-21(22(32)33)29-23(34)28-18-6-4-17(5-7-18)24(25,26)27/h4-11,21H,2-3,12-16H2,1H3,(H2,28,29,34)/t21-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 2.20E+3n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497406
PNG
(US11008301, Example 70)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCCC(F)(F)C2)cc1
Show InChI InChI=1S/C24H25F5N4O2/c25-23(26)12-2-13-32(15-23)18-8-10-19(11-9-18)33-14-1-3-20(21(33)34)31-22(35)30-17-6-4-16(5-7-17)24(27,28)29/h4-11,20H,1-3,12-15H2,(H2,30,31,35)/t20-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 67n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497407
PNG
(US11008301, Example 77)
Show SMILES CN(C)C1CCCN(C1)c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C26H32F3N5O2/c1-32(2)22-5-3-15-33(17-22)20-11-13-21(14-12-20)34-16-4-6-23(24(34)35)31-25(36)30-19-9-7-18(8-10-19)26(27,28)29/h7-14,22-23H,3-6,15-17H2,1-2H3,(H2,30,31,36)/t22?,23-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 0.180n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497410
PNG
(US11008301, Example 95)
Show SMILES Clc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2C[C@@H]3COC[C@@H]3C2)cc1
Show InChI InChI=1S/C24H27ClN4O3/c25-18-3-5-19(6-4-18)26-24(31)27-22-2-1-11-29(23(22)30)21-9-7-20(8-10-21)28-12-16-14-32-15-17(16)13-28/h3-10,16-17,22H,1-2,11-15H2,(H2,26,27,31)/t16-,17+,22-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 76n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497412
PNG
(US11008301, Example 104)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(nc2)N2C[C@@H]3CC[C@H](C2)O3)cc1
Show InChI InChI=1S/C24H26F3N5O3/c25-24(26,27)15-3-5-16(6-4-15)29-23(34)30-20-2-1-11-32(22(20)33)17-7-10-21(28-12-17)31-13-18-8-9-19(14-31)35-18/h3-7,10,12,18-20H,1-2,8-9,11,13-14H2,(H2,29,30,34)/t18-,19+,20-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 630n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497396
PNG
(US11008301, Example 14)
Show SMILES COCC1CCCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C26H31F3N4O3/c1-36-17-22-5-2-3-15-32(22)20-11-13-21(14-12-20)33-16-4-6-23(24(33)34)31-25(35)30-19-9-7-18(8-10-19)26(27,28)29/h7-14,22-23H,2-6,15-17H2,1H3,(H2,30,31,35)/t22?,23-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 2.10n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497396
PNG
(US11008301, Example 14)
Show SMILES COCC1CCCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C26H31F3N4O3/c1-36-17-22-5-2-3-15-32(22)20-11-13-21(14-12-20)33-16-4-6-23(24(33)34)31-25(35)30-19-9-7-18(8-10-19)26(27,28)29/h7-14,22-23H,2-6,15-17H2,1H3,(H2,30,31,35)/t22?,23-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 36n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497401
PNG
(US11008301, Example 45)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCCCC2)cc1
Show InChI InChI=1S/C24H27F3N4O2/c25-24(26,27)17-6-8-18(9-7-17)28-23(33)29-21-5-4-16-31(22(21)32)20-12-10-19(11-13-20)30-14-2-1-3-15-30/h6-13,21H,1-5,14-16H2,(H2,28,29,33)/t21-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 11n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497394
PNG
(US11008301, Example 9)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@H]2CCCN(C2=O)c2ccc(cc2)N2CC3(COC3)C2)cc1
Show InChI InChI=1S/C24H25F3N4O3/c25-24(26,27)16-3-5-17(6-4-16)28-22(33)29-20-2-1-11-31(21(20)32)19-9-7-18(8-10-19)30-12-23(13-30)14-34-15-23/h3-10,20H,1-2,11-15H2,(H2,28,29,33)/t20-/m0/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 540n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497401
PNG
(US11008301, Example 45)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCCCC2)cc1
Show InChI InChI=1S/C24H27F3N4O2/c25-24(26,27)17-6-8-18(9-7-17)28-23(33)29-21-5-4-16-31(22(21)32)20-12-10-19(11-13-20)30-14-2-1-3-15-30/h6-13,21H,1-5,14-16H2,(H2,28,29,33)/t21-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 3n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497407
PNG
(US11008301, Example 77)
Show SMILES CN(C)C1CCCN(C1)c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C26H32F3N5O2/c1-32(2)22-5-3-15-33(17-22)20-11-13-21(14-12-20)34-16-4-6-23(24(34)35)31-25(36)30-19-9-7-18(8-10-19)26(27,28)29/h7-14,22-23H,3-6,15-17H2,1-2H3,(H2,30,31,36)/t22?,23-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 1.10E+3n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497408
PNG
(US11008301, Example 81)
Show SMILES CN(C)C1CCN(C1)c1ccc(N2CCC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1
Show InChI InChI=1S/C24H28ClF2N5O2/c1-30(2)17-9-11-31(14-17)16-6-8-22(19(27)13-16)32-10-3-4-21(23(32)33)29-24(34)28-20-7-5-15(25)12-18(20)26/h5-8,12-13,17,21H,3-4,9-11,14H2,1-2H3,(H2,28,29,34)/t17?,21-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 0.310n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497394
PNG
(US11008301, Example 9)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@H]2CCCN(C2=O)c2ccc(cc2)N2CC3(COC3)C2)cc1
Show InChI InChI=1S/C24H25F3N4O3/c25-24(26,27)16-3-5-17(6-4-16)28-22(33)29-20-2-1-11-31(21(20)32)19-9-7-18(8-10-19)30-12-23(13-30)14-34-15-23/h3-10,20H,1-2,11-15H2,(H2,28,29,33)/t20-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 1.50E+3n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497398
PNG
(US11008301, Example 17)
Show SMILES COC[C@@H]1CCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cn2)C1=O
Show InChI InChI=1S/C23H28ClN5O3/c1-32-15-19-4-2-12-28(19)17-7-9-18(10-8-17)29-13-3-5-20(22(29)30)26-23(31)27-21-11-6-16(24)14-25-21/h6-11,14,19-20H,2-5,12-13,15H2,1H3,(H2,25,26,27,31)/t19-,20+/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 34n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497409
PNG
(US11008301, Example 83)
Show SMILES CN(C)C1CCN(C1)c1ccc(cc1F)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O
Show InChI InChI=1S/C24H29ClFN5O2/c1-29(2)19-11-13-30(15-19)22-10-9-18(14-20(22)26)31-12-3-4-21(23(31)32)28-24(33)27-17-7-5-16(25)6-8-17/h5-10,14,19,21H,3-4,11-13,15H2,1-2H3,(H2,27,28,33)/t19?,21-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 1.10E+3n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497410
PNG
(US11008301, Example 95)
Show SMILES Clc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2C[C@@H]3COC[C@@H]3C2)cc1
Show InChI InChI=1S/C24H27ClN4O3/c25-18-3-5-19(6-4-18)26-24(31)27-22-2-1-11-29(23(22)30)21-9-7-20(8-10-21)28-12-16-14-32-15-17(16)13-28/h3-10,16-17,22H,1-2,11-15H2,(H2,26,27,31)/t16-,17+,22-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 2.5n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497393
PNG
(US11008301, Example 4)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCCCC2=O)cc1
Show InChI InChI=1S/C24H25F3N4O3/c25-24(26,27)16-6-8-17(9-7-16)28-23(34)29-20-4-3-15-31(22(20)33)19-12-10-18(11-13-19)30-14-2-1-5-21(30)32/h6-13,20H,1-5,14-15H2,(H2,28,29,34)/t20-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 28n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497393
PNG
(US11008301, Example 4)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCCCC2=O)cc1
Show InChI InChI=1S/C24H25F3N4O3/c25-24(26,27)16-6-8-17(9-7-16)28-23(34)29-20-4-3-15-31(22(20)33)19-12-10-18(11-13-19)30-14-2-1-5-21(30)32/h6-13,20H,1-5,14-15H2,(H2,28,29,34)/t20-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 410n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497398
PNG
(US11008301, Example 17)
Show SMILES COC[C@@H]1CCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cn2)C1=O
Show InChI InChI=1S/C23H28ClN5O3/c1-32-15-19-4-2-12-28(19)17-7-9-18(10-8-17)29-13-3-5-20(22(29)30)26-23(31)27-21-11-6-16(24)14-25-21/h6-11,14,19-20H,2-5,12-13,15H2,1H3,(H2,25,26,27,31)/t19-,20+/m0/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 32n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497402
PNG
(US11008301, Example 50)
Show SMILES Fc1cc(ccc1N1CCC[C@@H](NC(=O)Nc2ccc(nc2)C(F)(F)F)C1=O)N1CCCCC1=O
Show InChI InChI=1S/C23H23F4N5O3/c24-16-12-15(31-10-2-1-5-20(31)33)7-8-18(16)32-11-3-4-17(21(32)34)30-22(35)29-14-6-9-19(28-13-14)23(25,26)27/h6-9,12-13,17H,1-5,10-11H2,(H2,29,30,35)/t17-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 330n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497403
PNG
(US11008301, Example 54)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(nc2)N2CCOCC2)cc1
Show InChI InChI=1S/C22H24F3N5O3/c23-22(24,25)15-3-5-16(6-4-15)27-21(32)28-18-2-1-9-30(20(18)31)17-7-8-19(26-14-17)29-10-12-33-13-11-29/h3-8,14,18H,1-2,9-13H2,(H2,27,28,32)/t18-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 31n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497404
PNG
(US11008301, Example 56)
Show SMILES OCC1CCCN(C1)c1ccc(cn1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C24H28F3N5O3/c25-24(26,27)17-5-7-18(8-6-17)29-23(35)30-20-4-2-12-32(22(20)34)19-9-10-21(28-13-19)31-11-1-3-16(14-31)15-33/h5-10,13,16,20,33H,1-4,11-12,14-15H2,(H2,29,30,35)/t16?,20-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 1.80n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497411
PNG
(US11008301, Example 102)
Show SMILES Clc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCC3(CCCO3)CC2)cc1
Show InChI InChI=1S/C26H31ClN4O3/c27-19-4-6-20(7-5-19)28-25(33)29-23-3-1-15-31(24(23)32)22-10-8-21(9-11-22)30-16-13-26(14-17-30)12-2-18-34-26/h4-11,23H,1-3,12-18H2,(H2,28,29,33)/t23-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 61n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497397
PNG
(US11008301, Example 15)
Show SMILES COCC1CCCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(nc2)C(F)(F)F)C1=O
Show InChI InChI=1S/C25H30F3N5O3/c1-36-16-20-5-2-3-13-32(20)18-8-10-19(11-9-18)33-14-4-6-21(23(33)34)31-24(35)30-17-7-12-22(29-15-17)25(26,27)28/h7-12,15,20-21H,2-6,13-14,16H2,1H3,(H2,30,31,35)/t20?,21-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 660n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
* indicates data uncertainty>20%